Examkin

Question

Difficulty: Very hardImmunizations and Vaccine-Preventable Diseases

Match each specific patient clinical scenario with the most appropriate immunization management strategy based on current CDC/ACIP guidelines.

  • A 30-year-old woman at 28 weeks gestation receiving eculizumab therapy for paroxysmal nocturnal hemoglobinuria.Administration of MenACWY and MenB vaccines is strongly indicated despite pregnancy, alongside routine third-trimester Tdap.
  • A 19-year-old nursing student with a confirmed history of severe anaphylaxis to baker's yeast.Hepatitis B vaccination is strictly contraindicated; other routine inactive vaccines may be safely administered.
  • A 45-year-old man with HIV (CD4 count 120 cells/mm³) preparing for travel to an endemic region in sub-Saharan Africa.Live-attenuated vaccines such as yellow fever and MMR are strictly contraindicated due to the degree of immunosuppression.
  • A 55-year-old woman who underwent an autologous hematopoietic stem cell transplant (HSCT) 24 months ago and is off all immunosuppressive therapy.Administration of live-attenuated vaccines (e.g., MMR, varicella) is now safe and indicated as part of the revaccination schedule.
  • A 60-year-old man with chronic lymphocytic leukemia on active targeted therapy who was exposed to varicella 3 days ago.Varicella-Zoster Immune Globulin (VZIG) is indicated for post-exposure prophylaxis; live varicella vaccine is contraindicated.

Answer

Patient 1 matches with MenACWY/MenB indication; Patient 2 matches with Hepatitis B contraindication; Patient 3 matches with yellow fever/MMR contraindication; Patient 4 matches with safe administration of live vaccines post-HSCT; Patient 5 matches with VZIG post-exposure prophylaxis.
Each patient's unique clinical risk profile dictates a highly specific vaccine strategy: terminal complement blockade via eculizumab mandates meningococcal coverage despite pregnancy; yeast anaphylaxis specifically precludes the Hepatitis B vaccine; severe HIV (CD4 < 200) precludes live vaccines; achieving the 24-month mark post-HSCT without immunosuppression allows the resumption of live vaccines; and active leukemia with varicella exposure requires passive immunity (VZIG) rather than live active vaccination.

Step-by-Step Solution

1
Evaluate the pregnant patient on eculizumab therapy.
Requires immediate meningococcal vaccination (MenACWY and MenB) and Tdap.
Eculizumab inhibits terminal complement, drastically increasing meningococcal risk. Both meningococcal vaccines are inactivated/recombinant and are safe and indicated during pregnancy when high-risk conditions are present.
2
Evaluate the nursing student with a history of severe anaphylaxis to baker's yeast.
Hepatitis B vaccine is strictly contraindicated.
The Hepatitis B vaccine is cultured in Saccharomyces cerevisiae (baker's yeast). A history of anaphylactic allergy to baker's yeast is a widely tested absolute contraindication.
3
Evaluate the HIV patient with a CD4 count of 120 cells/mm³ traveling to a yellow fever endemic area.
Live-attenuated vaccines (yellow fever, MMR) are contraindicated.
Severe immunosuppression (CD4 < 200 cells/mm³) precludes the use of live vaccines due to the risk of uncontrolled vaccine strain replication and disseminated disease.
4
Evaluate the autologous HSCT recipient at 24 months post-transplant.
Live-attenuated vaccines are now indicated.
At 24 months post-HSCT, assuming the absence of GVHD and immunosuppressive therapy for at least 3-11 months, the immune system has recovered sufficiently to safely receive live vaccines (MMR, varicella) as part of routine revaccination.
5
Evaluate the leukemia patient with recent varicella exposure.
Requires Varicella-Zoster Immune Globulin (VZIG).
Active leukemia treated with targeted therapy constitutes severe immunocompromise. Post-exposure prophylaxis cannot be achieved with the live varicella vaccine; passive immunity via VZIG must be administered.

Key Concept

Nuanced immunization indications and contraindications across highly specific special populations, including complex immunosuppression, pregnancy, and severe allergies.
Rate this question

Topics

Immunizations and Vaccine-Preventable Diseases

More questions from this topic